News
Important Only
Other
Synchrony Financial To Buy Lowe's Credit Card Portfolio - SEC Filing
Aug 5 (Reuters) - Synchrony Financial SYF.N:SYNCHRONY FINANCIAL - TO BUY LOWE'S CREDIT CARD PORTFOLIO - SEC FILINGSYNCHRONY FINANCIAL - EXPECTS TO RECORD UP TO $50 MILLION RESERVE IN Q3 RELATED TO ACQUISITION - SEC FILINGSource text: [ID:n0001601712-25-000239]Reuters
Tue, Aug 5
Other
Cloud platform DigitalOcean beats Q2 revenue beats estimates, raises FY guidance
OverviewDigitalOcean Q2 2025 revenue rises 14% yr/yr, beating analyst expectationsNet income for Q2 2025 increases 93% yr/yr to $37 mlnCompany raises full-year revenue guidance to $888-$892 mlnOutlookDigitalOcean sees Q3 revenue of $226 mln to $227 mlnCompany expects full-year revenue of $888 mln to...Reuters
Tue, Aug 5
Forex
EUR consolidates in quiet trade – Scotiabank
Despite firm Spanish and Italian Services and Composite PMI data for July and mild upward revisions for the German data, downward revisions for the French PMIs resulted in minor downward revisions to the Eurozone Services and Composite data for last month, Scotiabank's Chief FX Strategists Shaun Osb
Fxstreet
Tue, Aug 5
Other
Align Technology Inc - Plans $200 Million Stock Repurchase - SEC Filing
Align Technology Inc ALGN.O:ALIGN TECHNOLOGY INC - PLANS $200 MILLION STOCK REPURCHASE - SEC FILINGALIGN TECHNOLOGY INC - REPURCHASES EXPECTED TO COMPLETE BY JANUARY 2026 - SEC FILINGSource text: [ID:n0001097149-25-000059]Reuters
Tue, Aug 5
Other
Cadrenal Therapeutics Announces Clinical Trial Initiation Plans For Tecarfarin In Patients With End-Stage Kidney Disease (Eskd) Transitioning To Dialysis
Aug 5 (Reuters) - Cadrenal Therapeutics Inc CVKD.O:CADRENAL THERAPEUTICS ANNOUNCES CLINICAL TRIAL INITIATION PLANS FOR TECARFARIN IN PATIENTS WITH END-STAGE KIDNEY DISEASE (ESKD) TRANSITIONING TO DIALYSISCADRENAL THERAPEUTICS INC - ENROLLMENT FOR TECARFARIN TRIAL TO BEGIN LATER THIS YEARReuters
Tue, Aug 5
Other
Lemonade Announces Second Quarter 2025 Financial Results
Aug 5 (Reuters) - Lemonade Inc LMND.N:LEMONADE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTSLEMONADE INC OUTLOOK Q3 REVENUE $183 MILLION - $186 MILLION - SHAREHOLDER LETTERLEMONADE INC OUTLOOK FY REVENUE $710 MILLION - $715 MILLIONLEMONADE INC - REITERATE EXPECTATION OF POSITIVE ADJUSTED. FCF FOR ...Reuters
Tue, Aug 5
Other
Alight Q2 revenue beats estimates
OverviewAlight Q2 revenue falls 1.9% to $528 mln, beating analyst expectationsAdjusted EPS meets analyst expectations at $0.10, adjusted EBITDA missesCo incurs $983 mln goodwill impairment charge, impacting net incomeOutlookAlight forecasts 2025 revenue of $2,282 mln to $2,329 mlnCompany expects 202...Reuters
Tue, Aug 5
Other
Commercial real estate services provider Cushman & Wakefield's Q2 profit beats estimates
OverviewCushman & Wakefield Q2 revenue grows 9% yr/yr to $2.5 blnAdjusted EPS beats analyst expectations, reflecting strategic initiativesCo announces $150 mln term loan debt repayment, fortifying balance sheetOutlookCushman & Wakefield raises full-year earnings per share outlookResult Drive...Reuters
Tue, Aug 5
Other
Ranpak Q2 revenue up 6.8% but misses estimates, net loss narrows
OverviewRanpak Q2 revenue rises 6.8% yr/yr, but misses analysts' expectationsNet loss narrows to $7.5 mln, beats analysts' estimatesAdjusted EBITDA down 15.8%, missing expectationsOutlookRanpak forecasts H2 2025 net revenue of $216 - $230 mlnCompany expects H2 2025 AEBITDA of $44.5 - $54.5 m...Reuters
Tue, Aug 5
Commodities
COLUMN-Record production at Exxon and Chevron humbles European rivals: Bousso
Exxon, Chevron oil and gas production hit record in Q2Shell production drops to lowest in at least 20 years, BP's drops from year agoEuropean majors hope to close a valuation gap with US rivalsBy Ron Bousso LONDON, Aug 5 - When playing catch up, picking up the pace may not be enough. One also...Reuters
Tue, Aug 5
